CLYM

Climb Bio, Inc. is a biotechnology company based in Wilmington, Delaware, specializing in the development of innovative therapies for autoimmune-driven inflammatory diseases. With a strong and diverse pipeline of drug candidates, Climb Bio harnesses advanced scientific research to address significant unmet medical needs in this therapeutic area. The company’s strategic focus on research and development, combined with its commitment to enhancing patient outcomes, establishes Climb Bio as a vital entity within the biotechnology field, poised for potential growth and impact in the industry.